2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Surgical Wound Infection
5
Neoplasms
4
Colorectal Neoplasms
4
Sepsis
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Leukemia, Myeloid, Acute
2
Febrile Neutropenia
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Solitary Pulmonary Nodule
1
Skin Neoplasms
1
Pancreatic Fistula
1
Neutropenia
1
Neoplasms, Plasma Cell
1
Multiple Pulmonary Nodules
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Intestinal Neoplasms
1
Inflammation
1
Infections
1
Hematologic Neoplasms
1
Glioblastoma
1
Fever
1
Exanthema
1
Emergencies
1
Interventions
Fulvestrant
5
Exercise
5
Eating
5
Standard of Care
3
Sodium Chloride
3
Diet
3
Alpelisib
3
ribociclib
2
gallium Ga 68 dotatate
2
exemestane
2
Vitamin D
2
Tamoxifen
2
Magnetic Resonance Spectroscopy
2
Letrozole
2
Ethanol
2
Blood Specimen Collection
2
Anastrozole
2
zopiclone
1
ziprasidone
1
veliparib
1
testosterone undecanoate
1
testosterone enanthate
1
pazopanib
1
mirabegron
1
methyl hydroxyethyl cellulose
1
lenvatinib
1
fluorocholine
1
evolocumab
1
dimethandrolone-undecanoate
1
cyclopropapyrroloindole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Multiple Endocrine Neoplasia Type 1
×
Anti-Bacterial Agents
×
Clear all
NCT00764114
2013-05-06
DTS
Assistance Publique - Hôpitaux de Paris
Phase 4
Completed
351 enrolled